Evidence map›Paper›PMID 39712786›Full record

ReviewCureus2024

The Development of Ebola Virus Outbreaks: A Review of Epidemiological Trends, Clinical Features, and Treatment Advances.

Omar B Mohd, Seri Sawaqed, Mrinmoy Kundu, Reem A Ghannam, Ahmed B Mohd, Jehad F AlSamhori, Osama K Musallam, Abdalrahman Altiti, Hanan Hasan, Abdulrhman Khaity

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Omar B MohdFaculty of Medicine, Hashemite University, Zarqa, JOR.
Seri SawaqedFaculty of Medicine, Hashemite University, Zarqa, JOR.
Mrinmoy KunduCollege of Medicine, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, IND.
Reem A GhannamFaculty of Medicine, Hashemite University, Zarqa, JOR.
Ahmed B MohdFaculty of Medicine, Hashemite University, Zarqa, JOR.
Jehad F AlSamhoriFaculty of Medicine, The University of Jordan, Amman, JOR.
Osama K MusallamFaculty of Medicine, Hashemite University, Zarqa, JOR.
Abdalrahman AltitiFaculty of Medicine, Hashemite University, Zarqa, JOR.
Hanan HasanMedical Laboratory, The Lab, Amman, JOR.
Abdulrhman KhaityFaculty of Medicine, University of Khartoum, Khartoum, SDN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Ebola virus, a filovirus that causes human Ebola virus disease (EVD), has caused multiple epidemics in the African continent for about 50 years. Wild animals were the source from which the virus was transmitted to humans, and it spread among people through direct contact. The majority of Ebola outbreaks occurred in African nations, particularly in Sudan, the Democratic Republic of the Congo (DRC), Uganda, and Gabon. Although EVD is a lethal disease, it has posed a challenge to human efforts to comprehend its etiology, epidemiology, pathophysiology, pathogenesis, and the best methods for treatment and prevention. This review aims to present the history of Ebola epidemics in Africa, each subtype that caused an outbreak, the development of therapies and vaccines, and the significance of travel regulations.

Indexed as

ebolaebola outbreakebola virusglobal epidemiologyinfectious disease outbreaks

Identifiers

PMID39712786
PMCPMC11660724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.